These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38721901)

  • 1. Using Machine Learning and miRNA for the Diagnosis of Esophageal Cancer.
    Aravind VA; Kouznetsova VL; Kesari S; Tsigelny IF
    J Appl Lab Med; 2024 Jul; 9(4):684-695. PubMed ID: 38721901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Aggressive Movements Using Smartwatches.
    Tchuente F; Baddour N; Lemaire ED
    Sensors (Basel); 2020 Nov; 20(21):. PubMed ID: 33182258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Machine Learning Techniques for Traffic Flow-Based Intrusion Detection.
    Rodríguez M; Alesanco Á; Mehavilla L; García J
    Sensors (Basel); 2022 Nov; 22(23):. PubMed ID: 36502028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.
    Lopez-Rincon A; Martinez-Archundia M; Martinez-Ruiz GU; Schoenhuth A; Tonda A
    BMC Bioinformatics; 2019 Sep; 20(1):480. PubMed ID: 31533612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Hybrid Model for the Prediction of Chronic Kidney Disease.
    Khalid H; Khan A; Zahid Khan M; Mehmood G; Shuaib Qureshi M
    Comput Intell Neurosci; 2023; 2023():9266889. PubMed ID: 36959840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning integrated ensemble of feature selection methods followed by survival analysis for predicting breast cancer subtype specific miRNA biomarkers.
    Sarkar JP; Saha I; Sarkar A; Maulik U
    Comput Biol Med; 2021 Apr; 131():104244. PubMed ID: 33550016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning.
    Gupta R; Kleinjans J; Caiment F
    BMC Cancer; 2021 Aug; 21(1):962. PubMed ID: 34445986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
    Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
    Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Sequence Similarity Based on CKSNP Features and a Graph Neural Network Model to Identify miRNA-Disease Associations.
    Li M; Fan Y; Zhang Y; Lv Z
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods.
    Taghizadeh E; Heydarheydari S; Saberi A; JafarpoorNesheli S; Rezaeijo SM
    BMC Bioinformatics; 2022 Oct; 23(1):410. PubMed ID: 36183055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective.
    Li X; Dai A; Tran R; Wang J
    Breast Cancer Res Treat; 2023 Aug; 201(1):5-14. PubMed ID: 37329459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression.
    Zhao Y; Xu L; Wang X; Niu S; Chen H; Li C
    Mol Oncol; 2021 Apr; 15(4):1088-1109. PubMed ID: 33463006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of lung cancer serum biomarkers based on Boruta-shap and RFC-RFECV algorithms.
    Yue G
    J Proteomics; 2024 Jun; 301():105180. PubMed ID: 38663548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of microRNAs as potential biomarkers for detecting esophageal carcinoma in Asian populations.
    Li M; Wu F; Ji Y; Yang L; Li F
    Int J Biol Markers; 2017 Oct; 32(4):e375-e383. PubMed ID: 28862713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of serum markers of esophageal squamous cell carcinoma based on machine learning methods.
    Ma Z; Zhu T; Wang H; Wang B; Fu L; Yu G
    J Biochem; 2022 Jun; 172(1):29-36. PubMed ID: 35415740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction.
    Chen X; Huang L
    PLoS Comput Biol; 2017 Dec; 13(12):e1005912. PubMed ID: 29253885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.